This meeting will proceed in-person. If you are currently unable to register due to temporary travel restrictions, you can sign up for updates here for this specific conference only. Our team will keep you updated regarding deadline reminders and grant opportunities. We hope this service is helpful if your organisation still restricts travel.
This conference is a continuation of the Fibroblast Growth Factors in Development and Repair series with an expanded scope that includes other growth factors and cytokines that are involved in tissue repair and regeneration/regenerative medicine.
The Growth Factors in Regeneration and Regenerative Medicine Fusion Conference aims to bring together researchers and clinicians from different disciplines with an interest in the function of growth factors in tissue regeneration and their use for regenerative medicine. This meeting will provide a unique opportunity for academic and industrial researchers and clinicians to meet each other, to discuss projects, and to initiate new and in some cases highly interdisciplinary research projects and collaborations.
- Role of growth factors in stem cell biology
- Extracellular matrix regulation of growth factor signalling in tissue repair and regeneration
- Vasculature in tissue repair and regeneration
- Immune system in repair and regeneration
- Growth factor function in tissue repair vs. cancer
- Growth factor-based tissue engineering for repair and regeneration
Take advantage of this fantastic opportunity for students! Fully paying academics can bring a student for only $890. Unfortunately, Postdocs are not eligible. Both registration packages include; accommodation for the 09, 10, 11 February 2023 (on a shared basis for students) and a 24hour all-inclusive food and beverage package for the conference period. Once registered, please contact Amy Johnson to obtain a special registration link for your student.
Confirmed Invited Speakers:
Sabine Eming (University of Cologne)
MACROPHAGE MEDIATED WOUND ANGIOGENESIS
Jeffrey Hubbell (University of Chicago)
ENHANCING CYTOKINE FUNCTION THROUGH BINDING TO EXTRACELLULAR MATRIX
Luisa Iruela-Arispa (Northwestern University)
MECHANISMS REGULATING VASCULAR GROWTH AND REGENERATION
Mike Longaker (Stanford School of Medicine)
WOUND REPAIR WITH REGENERATION WITHOUT SCARRING
Paul Martin (University of Bristol)
WOUND HEALING INSIGHTS FROM FISH AND FLIES
Andrew McMahon (University of Southern California)
A WNT-MEDIATED TRANSCRIPTIONAL SWITCH BALANCES EXPANSION AND COMMITMENT OF NEPHRON PROGENITORS
Helen McNeill (Washington University)
FAT CADHERINS IN GROWTH CONTROL AND REGENERATION
Ken Muneoka (Texas A&M University)
BMP9 SIGNALING IN DIGIT REGENERATION AND REGENERATIVE MEDICINE
Kristy Red-Horse (Stanford University)
WHEN TWO ROADS MEET DURING DEVELOPMENT: CONVERGENT CELL DIFFERENTIATION IN THE MOUSE AND HUMAN HEART
Maria Sibilia (Medical University Vienna)
MICROENVIRONMENTAL DRIVERS OF INFLAMMATION AND TUMORIGENESIS
Eileen Shore (University of Pennsylvania)
HETEROTOPIC OSSIFICATION – A DISORDER OF TISSUE REPAIR?
Lewis T. (Rusty) Williams (Walking Fish Therapeutics)
USING B CELLS TO DELIVER THERAPEUTIC PROTEINS TO SPECIFIC TISSUES
Thomas Wynn (Pfizer)
TYPE 2 IMMUNITY AND MACROPHAGE SUBSETS IN FIBROSIS, TISSUE REPAIR, AND REGENERATION
Growth factors control survival, proliferation, migration, metabolic functions and the gene expression program of all cells in the body. Upon injury, expression of many growth factors is upregulated, thereby stimulating proliferation and migration of cells at the site of injury. The correct interplay among different growth factors and their cross-talk with other injury-relevant signals is crucial for normal repair. While certain lower organisms have a strong regenerative capacity and can even regenerate complete amputated limbs, this capability is rudimentary in mammals where tissue injury most often results in scar formation with functional and aesthetical impairment. Therefore, there is a strong need to develop strategies to improve the repair/regeneration process. A detailed understanding of growth factor function in regenerating vs non-regenerating tissues and organisms will help to design such strategies. Based on this knowledge, the application of growth factors to injured tissues or activation of major growth factor signaling pathways has a strong potential to improve tissue regeneration. Such approaches require not only the design of suitable molecules, but also their appropriate delivery. All these aspects will be addressed at the Fusion Conference. The meeting is therefore of major interest for cell and developmental biologists, researchers and clinicians working in the area of tissue repair and regeneration, pharmacologists and bioengineers. We expect this meeting to attract people from academia, but also from various Biotechnology and pharmaceutical companies.
Growth factor research as well as tissue repair research are well represented at different places in the world, with major hubs in Europe, in the US, and in China. However, researchers from other countries also join such conferences.
Research on Growth Factor signalling pathways in stem cell biology, as mediators of tissue injury, and as potential therapeutics in regenerative medicine is rapidly progressing. Because of the rapid progress in these clinically relevant areas, there is a critical need to bring together researchers from academia and from the Biotechnology and Pharmaceutical industries, and clinicians, to share ideas and establish collaborations. There is an additional need to educate new researchers on the recent progress in understanding growth factors as mediators of disease and their use as therapeutics for regenerative medicine.